MX2009002402A - Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms. - Google Patents

Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms.

Info

Publication number
MX2009002402A
MX2009002402A MX2009002402A MX2009002402A MX2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A MX 2009002402 A MX2009002402 A MX 2009002402A
Authority
MX
Mexico
Prior art keywords
glms
riboswitches
glms riboswitches
compositions
methods
Prior art date
Application number
MX2009002402A
Other languages
English (en)
Inventor
Ronald R Breaker
Jinsoo Lim
Scotta A Strobel
Jesse C Cochrane
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of MX2009002402A publication Critical patent/MX2009002402A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/50—Molecular design, e.g. of drugs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Computing Systems (AREA)
  • Theoretical Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

El ribointerruptor de glmS en un blanco para antibióticos y otras terapias de moléculas pequeñas. Los compuestos pueden utilizarse para estimular, activar, inhibir y/o inactivar el ribointerruptor de glmS. Las estructuras atómicas del ribointerruptor de glmS pueden usarse para diseñar nuevos compuestos con el fin de estimular, activar, inhibir y/o inactivar ribointerruptores.
MX2009002402A 2006-09-06 2007-09-06 Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms. MX2009002402A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84287006P 2006-09-06 2006-09-06
US84484406P 2006-09-16 2006-09-16
PCT/US2007/019456 WO2008076156A2 (en) 2006-09-06 2007-09-06 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches

Publications (1)

Publication Number Publication Date
MX2009002402A true MX2009002402A (es) 2009-04-02

Family

ID=39536867

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009002402A MX2009002402A (es) 2006-09-06 2007-09-06 Ribointerruptores de glms, diseño de compuesto basado en su estructura con ribointerruptores de glms y metodos y composiciones para el uso de los mismos y con ribointerruptores de glms.

Country Status (9)

Country Link
US (1) US20100324123A1 (es)
EP (1) EP2061480A4 (es)
JP (1) JP2010503619A (es)
KR (1) KR20090073131A (es)
AU (1) AU2007334618A1 (es)
CA (1) CA2662506A1 (es)
MX (1) MX2009002402A (es)
SG (1) SG175549A1 (es)
WO (1) WO2008076156A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003288906C1 (en) 2002-09-20 2010-12-09 Yale University Riboswitches, methods for their use, and compositions for use with riboswitches.
WO2007100412A2 (en) 2005-12-21 2007-09-07 Yale University Methods and compositions related to the modulation of riboswitches
CN107760643B (zh) * 2017-11-15 2020-10-09 江南大学 一种提高枯草芽孢杆菌乙酰氨基葡萄糖产量的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007100412A2 (en) * 2005-12-21 2007-09-07 Yale University Methods and compositions related to the modulation of riboswitches

Also Published As

Publication number Publication date
EP2061480A4 (en) 2011-07-13
CA2662506A1 (en) 2008-06-26
KR20090073131A (ko) 2009-07-02
JP2010503619A (ja) 2010-02-04
EP2061480A2 (en) 2009-05-27
WO2008076156A3 (en) 2009-04-16
WO2008076156A2 (en) 2008-06-26
US20100324123A1 (en) 2010-12-23
SG175549A1 (en) 2011-11-28
AU2007334618A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
MX2009012773A (es) Ribointerruptores y metodos y composiciones para usarse de y con ribointerruptores.
TN2010000131A1 (en) Polo-like kinase inhibitors
UA104731C2 (ru) Ингибиторы р38 мар-киназ
CL2008003041A1 (es) Compuestos derivados de acido boronico, inhibidores de proteasoma; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
ZA200902384B (en) Heteroaryl compounds, compositions thereof, and use thereof as protein kinase inhibitors
GT200600171A (es) Proceso quimico
EA201300200A1 (ru) N-((6-аминопиридин-3-ил)метил)гетероарилкарбоксамиды в качестве ингибиторов калликреина в плазме
MX336381B (es) Boronatos como inhibidores de arginasa.
TN2016000081A1 (en) Aminoheteroaryl benzamides as kinase inhibitors
MX2009004077A (es) Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
PH12016500072A1 (en) Piperidinyl-indole derivatives complement factor b inhibitors and uses thereof
BR112012019511A2 (pt) compostos de pirrolo [2,3-d] pirimidina como inibidores de jak.
MY159230A (en) P38 map kinase inhibitors
NZ620020A (en) Heterocyclic compounds and uses thereof
MX338707B (es) Compuestos heterociclicos activadores de proteina cinasa activada por 5'-amp (ampk) y metodos para emplearlos.
UY33984A (es) Uso de 2,3-dihidroimidazo [1,2-c] quinazolinas sustituidas
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
GB201021864D0 (en) Organic compounds
EA201170680A1 (ru) Ингибиторы акт и p70 s6-киназы
BR112014012983A2 (pt) derivados de pirrol
CL2011001026A1 (es) Uso de pimobedan para preparar un medicamento util en el tratamiento de cardiomiopatia hipertrofica en un gato.
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.
IN2015DN03235A (es)
EA201190236A1 (ru) Новые производные стероидных соединений [3,2-c]пиразолов с глюкокортикоидной активностью

Legal Events

Date Code Title Description
FG Grant or registration